Evidence map›Paper›PMID 40799850›Full record

ArticleThe journal of cardiovascular aging2024

Aging diastole - root cause for atrial fibrillation and heart failure with preserved ejection fraction.

Markus Meyer, Julio Núñez, Parag Goyal, Daniel N Silverman, Jop H van Berlo, Valmiki Maharaj

Abstract read
In one paragraph

Article in The journal of cardiovascular aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Markus MeyerLillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Julio NúñezCardiology Department, Hospital Clínico Universitario, INCLIVA, Universitat de València, València 46010, Spain.
Parag GoyalProgram for the Care and Study of the Aging Heart, Department of Medicine, Weill Cornell Medicine, New York, NY 10021, USA.
Daniel N SilvermanDivision of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
Jop H van BerloLillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Valmiki MaharajLillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.

Funding

Immune Mechanisms Regulating Cardiac RemodelingR01HL155993 · NHLBI · UNIVERSITY OF MINNESOTA · PI REVELO, XAVIER, VAN BERLO, JOHANNES (JOP) · 2021 to 2024
$2.9M
Computational and Experimental Modeling of Cardiomyocyte ProliferationR01HL160665 · NHLBI · UNIVERSITY OF VIRGINIA · PI SAUCERMAN, JEFFREY J., VAN BERLO, JOHANNES (JOP) · 2022 to 2025
$2.8M
A Novel Deprescribing Intervention for Heart Failure with Preserved Ejection Fraction (HFpEF): A Prototype for Older Adults with Multimorbidity and PolypharmacyK76AG064428 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI GOYAL, PARAG · 2020 to 2024
$1.1M
NHLBI NIH HHS R01 HL155993NHLBI NIH HHS R01 HL160665NIA NIH HHS K76 AG064428
6 · The paper itself

Abstract

The age-related decline in diastolic function can result in heart failure with a preserved ejection fraction (HFpEF) and atrial fibrillation (AF), which are comorbid conditions that are increasingly prevalent and have a high socioeconomic burden. In humans, diastolic dysfunction results from structural and functional changes that increasingly impede diastolic filling after midlife. Comorbidities and pathomechanisms that lead to additional increases in cardiac filling pressures accelerate the age-related deterioration in diastolic function. It is, therefore, that targeting the accelerators of diastolic dysfunction holds the most promise in reducing the risk for HFpEF and AF.

Indexed as

cardiac filling pressurescardiac remodelingdiastolic functionejection fractionHeart failureheart rate

Identifiers

PMID40799850
PMCPMC12341472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.